SlideShare a Scribd company logo
1 of 4
Acute Care Pharmacy
The purpose of the Adult Acute Care Pharmacy Practice rotation is to allow students to gain
experience and develop skills in various roles in which a pharmacist contributes to patient care in an
inpatient setting.
Prior to the rotation, the student should download the Checklist for All Rotations and the Adult
Acute Care Rotation Checklist to be used as guides for student activities during the rotation.
Preceptors may download an Adult Acute Care Rotation Syllabus template to use as a guide to
create a syllabus for their rotation.
Adult Acute Care Rotation Goals/Objectives
The following are guidelines regarding the activities in which students should gain experience or at
least exposure during the Adult Acute Care Rotation. These may be modified to accommodate the
student’s previous experience and goals as well as the preceptor's expertise and unique
characteristics of a practice site.
Overall ratings of the accomplishment of checklist tasks are reflected in items 1 and 2
(Knowledge/Application section) of the form used for the final rotation evaluation and grade
assignment.
1. Clinical Pharmacist General Skills
• Defines responsibilities of a clinical pharmacy consultant.
• Describes strategies for getting clinical pharmacy recommendations implemented.
• Describes strategies for dealing with patients or health care providers unhappy with clinical
pharmacy recommendations.
• Explains strategies for prioritizing clinical pharmacy duties and deciding which patients
should receive clinical pharmacy services first when time/staffing is limited such that all patients
can’t be seen by a pharmacist.
• Describes working structure of the practice site and pharmacy department, including
functions of various personnel and their relationship to the pharmacist
• Explains and demonstrates aspects of professionalism pertinent to clinical pharmacists.
• Demonstrates knowledge of billing procedures applicable to pharmacy services
2. Health Care Planning and Medication Therapy Management
• Collects, organizes, and evaluates patient information from various sources including the
patient chart, laboratory reports, medication administration records, communications with
patient/other health care providers.
• Evaluates existing medication therapy including indications of current medications;
medication reconciliation on patient admission or transfer; appropriate dosing with respect to age,
renal/liver function, alcohol use, and concurrent disease states; appropriate route of administration
with respect to GI functional status and other patient specific characteristics; drug-drug interactions;
applicable compliance issues; and monitoring parameters.
• Applies disease state knowledge to evaluate therapeutic options for given diagnoses. When
recommending therapy, considers individual patient contraindications to medications such as
allergies, concurrent disease states, and potential drug interactions; recommends appropriate dosing
with respect to age renal/liver function, alcohol use, and concurrent disease states; and makes
appropriate recommendations for monitoring therapy for adverse effects as well as desired
outcomes
• Considers social/economic issues that may affect therapy such as patient’s cultural
influences, attitude towards care, and personal resources; medication cost; formulary status of
medications desired by patient/physician.
• Identifies appropriate interventions based on above factors.
3. Patient Care Activities
• Reviews/processes medication orders appropriately, if applicable to rotation site.
• Performs medication reconciliation activities for newly admitted/transferred patients
• Participates in patient care rounds/conferences, analyzing each case presented, answering
drug information inquiries in timely manner using appropriate references and research, identifying
pertinent questions/issues that are not asked by the other members of the team, and effectively
communicating with other members of the health care team.
• When appropriate, provides patient education regarding disease state including usual course
of disease progression with and without treatment; usual drug and non-drug therapies; and general
precautions and recommended lifestyle modifications.
• When appropriate, provides patient education regarding medication therapy including
indication; dosing/instructions for use; potential side effects and precautions; and potential solutions
to compliance problems.
• Performs monitoring activities to assess efficacy and potential toxicity of drug therapies
while patient is admitted, reporting status to health care team and patient when appropriate.
Appropriately explains monitoring goals to patient as well as other health care professionals
• Demonstrates communication skills needed for interacting with patients health care team
including clear articulation; appropriate terminology; use of open ended questions; prioritization of
discussion points; active listening; caring attitude; provision of complete and accurate information.
Students should also become familiar with resources available at practice site for communication
with non-English speaking patients.
• Documents patient care activities according to rotation site procedures
4. Disease State/Therapeutic Knowledge
• Demonstrates knowledge of conditions commonly encountered in adult acute care settings,
such as diabetes, hypertension, acute coronary syndromes, stroke, asthma/COPD, clotting disorders,
acute organ failure, acute/serious infections, trauma. The list should reflect conditions most
pertinent to the preceptor’s practice. For these conditions, students should be able to describe basic
epidemiology (prevalence/incidence); basic pathophysiology and natural course; usual therapies;
situations in which usual therapy is not appropriate for an individual patient; goals of therapy;
monitoring parameters; and strategies to prevent complications or acute relapse of the disease.
• Demonstrates basic skills in therapeutic drug monitoring including knowledge of drugs
commonly monitored using serum concentrations and their usual therapeutic ranges; accurate
interpretation of drug concentrations considering timing of sampling with respect to drug
administration and other patient specific factors; and recommends appropriate adjustments to
therapy based on drug concentrations, using applicable calculations.
• Demonstrates basic skills in anticoagulation monitoring including knowledge of indications
for prophylactic and therapeutic anticoagulation in hospitalized patients; monitoring parameters for
heparin, warfarin, and other anticoagulants; and knowledge of anticoagulant intensity and duration
desired for different anticoagulant indications.
• Explains monitoring of insulin and oral hypoglycemic agents for efficacy and toxicity,
identifying particular concerns for hospitalized patients.
• Explains indications for IV hydration and considerations in selecting a particular fluid and
rate of administration.
• Explains essential considerations in assessing a patient’s acid-base balance
• Explains methods for estimation of renal function and drug dosing implications for
commonly used agents.
• Explains considerations for appropriate use of antibiotics in hospitalized patients including
the process for selecting empiric antibiotic use in a non-neutropenic febrile patient; pathogens
commonly associated with different types of infections; typical spectrum of activity of commonly
used antibiotics; interpretation of gram stain and culture data; adjustments to antibiotic therapy that
may be based on culture data; relative costs and potential formulary restrictions of antibiotics used
in an institution; duration of antibiotic therapy for different indications; monitoring parameters;
aminoglycoside monitoring and dose adjustments.
• Demonstrates understanding of basic concepts of nutrition support in hospitalized patients
including identification of appropriate candidates for enteral and parenteral nutrition, factors that
determine initial TPN/enteral formula for a patient; how/why the initial formula may change during
therapy; monitoring required for TPN patients; potential adverse effects of TPN; and factors that
determine when/how a TPN should be discontinued.
• Demonstrates knowledge of basic concepts of acute pain management including when and
how to initiate, monitor, adjust, and discontinue analgesic therapy; assessment of pain; indications
for use of opioids, NSAIDs, and other agents used for pain; adverse events associated with opioid
and non-opioid analgesics; methods for converting IV analgesics to PO and changing from one
opioid compound to another
•

More Related Content

More from M. Luisetto Pharm.D.Spec. Pharmacology

Current Research in Vaccines ACCEPTATION LETTER m R.N.A. PURIFICATIONS PROCES...
Current Research in Vaccines ACCEPTATION LETTER m R.N.A. PURIFICATIONS PROCES...Current Research in Vaccines ACCEPTATION LETTER m R.N.A. PURIFICATIONS PROCES...
Current Research in Vaccines ACCEPTATION LETTER m R.N.A. PURIFICATIONS PROCES...
M. Luisetto Pharm.D.Spec. Pharmacology
 
Graphene Derivates Carbon Products and Separation Properties : the M R.N.A. P...
Graphene Derivates Carbon Products and Separation Properties : the M R.N.A. P...Graphene Derivates Carbon Products and Separation Properties : the M R.N.A. P...
Graphene Derivates Carbon Products and Separation Properties : the M R.N.A. P...
M. Luisetto Pharm.D.Spec. Pharmacology
 
m R.N.A. Purifications Process: Affinity Chromato-Graphy, Magnetic Beads and ...
m R.N.A. Purifications Process: Affinity Chromato-Graphy, Magnetic Beads and ...m R.N.A. Purifications Process: Affinity Chromato-Graphy, Magnetic Beads and ...
m R.N.A. Purifications Process: Affinity Chromato-Graphy, Magnetic Beads and ...
M. Luisetto Pharm.D.Spec. Pharmacology
 
Acceptance letter j. of forensic research OPAST - White paper on Covid- 19 a...
Acceptance letter j. of forensic research OPAST - White paper on  Covid- 19 a...Acceptance letter j. of forensic research OPAST - White paper on  Covid- 19 a...
Acceptance letter j. of forensic research OPAST - White paper on Covid- 19 a...
M. Luisetto Pharm.D.Spec. Pharmacology
 
Raman (Rs) Spettroscopy for Biopharmaceutical Quality Control and Pat Raw Mat...
Raman (Rs) Spettroscopy for Biopharmaceutical Quality Control and Pat Raw Mat...Raman (Rs) Spettroscopy for Biopharmaceutical Quality Control and Pat Raw Mat...
Raman (Rs) Spettroscopy for Biopharmaceutical Quality Control and Pat Raw Mat...
M. Luisetto Pharm.D.Spec. Pharmacology
 
WHITE PAPER - m RNA vaccine production Quality control- regulatory and toxic...
WHITE PAPER - m RNA vaccine production Quality control-  regulatory and toxic...WHITE PAPER - m RNA vaccine production Quality control-  regulatory and toxic...
WHITE PAPER - m RNA vaccine production Quality control- regulatory and toxic...
M. Luisetto Pharm.D.Spec. Pharmacology
 
SWJPS-Graphene and Derivates Physico-Chemical and Toxicology Properties in th...
SWJPS-Graphene and Derivates Physico-Chemical and Toxicology Properties in th...SWJPS-Graphene and Derivates Physico-Chemical and Toxicology Properties in th...
SWJPS-Graphene and Derivates Physico-Chemical and Toxicology Properties in th...
M. Luisetto Pharm.D.Spec. Pharmacology
 
MENTAL ENERGY cover image by ALESSANDRA FALEGGI-Authors luisetto M et al 202...
MENTAL ENERGY cover image by ALESSANDRA FALEGGI-Authors luisetto M et  al 202...MENTAL ENERGY cover image by ALESSANDRA FALEGGI-Authors luisetto M et  al 202...
MENTAL ENERGY cover image by ALESSANDRA FALEGGI-Authors luisetto M et al 202...
M. Luisetto Pharm.D.Spec. Pharmacology
 
Cbi 7 cypress certificate luisetto m prof.ssorship pharmacology toxicology
Cbi 7 cypress certificate luisetto m prof.ssorship pharmacology   toxicologyCbi 7 cypress certificate luisetto m prof.ssorship pharmacology   toxicology
Cbi 7 cypress certificate luisetto m prof.ssorship pharmacology toxicology
M. Luisetto Pharm.D.Spec. Pharmacology
 

More from M. Luisetto Pharm.D.Spec. Pharmacology (20)

Teoria del libro PLUS IMAGO- PHILOSOPHIA ET SCIENTIA.pdf
Teoria del libro PLUS IMAGO- PHILOSOPHIA ET SCIENTIA.pdfTeoria del libro PLUS IMAGO- PHILOSOPHIA ET SCIENTIA.pdf
Teoria del libro PLUS IMAGO- PHILOSOPHIA ET SCIENTIA.pdf
 
ICRJ-2-1071 Monoliths in the mRNA Vaccine Purification Process the Silica Res...
ICRJ-2-1071 Monoliths in the mRNA Vaccine Purification Process the Silica Res...ICRJ-2-1071 Monoliths in the mRNA Vaccine Purification Process the Silica Res...
ICRJ-2-1071 Monoliths in the mRNA Vaccine Purification Process the Silica Res...
 
Current Research in Vaccines ACCEPTATION LETTER m R.N.A. PURIFICATIONS PROCES...
Current Research in Vaccines ACCEPTATION LETTER m R.N.A. PURIFICATIONS PROCES...Current Research in Vaccines ACCEPTATION LETTER m R.N.A. PURIFICATIONS PROCES...
Current Research in Vaccines ACCEPTATION LETTER m R.N.A. PURIFICATIONS PROCES...
 
Graphene Derivates Carbon Products and Separation Properties : the M R.N.A. P...
Graphene Derivates Carbon Products and Separation Properties : the M R.N.A. P...Graphene Derivates Carbon Products and Separation Properties : the M R.N.A. P...
Graphene Derivates Carbon Products and Separation Properties : the M R.N.A. P...
 
m R.N.A. Purifications Process: Affinity Chromato-Graphy, Magnetic Beads and ...
m R.N.A. Purifications Process: Affinity Chromato-Graphy, Magnetic Beads and ...m R.N.A. Purifications Process: Affinity Chromato-Graphy, Magnetic Beads and ...
m R.N.A. Purifications Process: Affinity Chromato-Graphy, Magnetic Beads and ...
 
JOURNAL OF FORENSIC PATHOLOGY ARTICLE IN PRESS LUISETTO ET AL 2022.docx
JOURNAL OF FORENSIC PATHOLOGY ARTICLE IN PRESS LUISETTO ET AL 2022.docxJOURNAL OF FORENSIC PATHOLOGY ARTICLE IN PRESS LUISETTO ET AL 2022.docx
JOURNAL OF FORENSIC PATHOLOGY ARTICLE IN PRESS LUISETTO ET AL 2022.docx
 
Acceptance letter j. of forensic research OPAST - White paper on Covid- 19 a...
Acceptance letter j. of forensic research OPAST - White paper on  Covid- 19 a...Acceptance letter j. of forensic research OPAST - White paper on  Covid- 19 a...
Acceptance letter j. of forensic research OPAST - White paper on Covid- 19 a...
 
Raman (Rs) Spettroscopy for Biopharmaceutical Quality Control and Pat Raw Mat...
Raman (Rs) Spettroscopy for Biopharmaceutical Quality Control and Pat Raw Mat...Raman (Rs) Spettroscopy for Biopharmaceutical Quality Control and Pat Raw Mat...
Raman (Rs) Spettroscopy for Biopharmaceutical Quality Control and Pat Raw Mat...
 
WHITE PAPER - m RNA vaccine production Quality control- regulatory and toxic...
WHITE PAPER - m RNA vaccine production Quality control-  regulatory and toxic...WHITE PAPER - m RNA vaccine production Quality control-  regulatory and toxic...
WHITE PAPER - m RNA vaccine production Quality control- regulatory and toxic...
 
SWJPS-Graphene and Derivates Physico-Chemical and Toxicology Properties in th...
SWJPS-Graphene and Derivates Physico-Chemical and Toxicology Properties in th...SWJPS-Graphene and Derivates Physico-Chemical and Toxicology Properties in th...
SWJPS-Graphene and Derivates Physico-Chemical and Toxicology Properties in th...
 
MENTAL ENERGY cover image by ALESSANDRA FALEGGI-Authors luisetto M et al 202...
MENTAL ENERGY cover image by ALESSANDRA FALEGGI-Authors luisetto M et  al 202...MENTAL ENERGY cover image by ALESSANDRA FALEGGI-Authors luisetto M et  al 202...
MENTAL ENERGY cover image by ALESSANDRA FALEGGI-Authors luisetto M et al 202...
 
ACCEPTATION LETTER SWJPS Review comment Form (swjps-1-107) Graphene and Deri...
ACCEPTATION LETTER SWJPS Review  comment Form (swjps-1-107) Graphene and Deri...ACCEPTATION LETTER SWJPS Review  comment Form (swjps-1-107) Graphene and Deri...
ACCEPTATION LETTER SWJPS Review comment Form (swjps-1-107) Graphene and Deri...
 
IMA 2022 Marijnskaya certificate GRAPHENE and DERIVATES chemico -physical ...
IMA  2022 Marijnskaya certificate GRAPHENE and  DERIVATES  chemico -physical ...IMA  2022 Marijnskaya certificate GRAPHENE and  DERIVATES  chemico -physical ...
IMA 2022 Marijnskaya certificate GRAPHENE and DERIVATES chemico -physical ...
 
EDITORIAL GRAPHENE and DERIVATES CHEMICO-PHYSICAL AND TOXICOLOGICAL PROPERT...
EDITORIAL  GRAPHENE and DERIVATES  CHEMICO-PHYSICAL AND TOXICOLOGICAL PROPERT...EDITORIAL  GRAPHENE and DERIVATES  CHEMICO-PHYSICAL AND TOXICOLOGICAL PROPERT...
EDITORIAL GRAPHENE and DERIVATES CHEMICO-PHYSICAL AND TOXICOLOGICAL PROPERT...
 
Pdf Book -GRAPHENE and DERIVATES PHYSICO- CHEMICAL AND TOXICOLOGY properti...
Pdf Book -GRAPHENE and  DERIVATES  PHYSICO- CHEMICAL  AND TOXICOLOGY properti...Pdf Book -GRAPHENE and  DERIVATES  PHYSICO- CHEMICAL  AND TOXICOLOGY properti...
Pdf Book -GRAPHENE and DERIVATES PHYSICO- CHEMICAL AND TOXICOLOGY properti...
 
Sars-cov2 Spike protein and derivates toxicology :fertility and teratogen eva...
Sars-cov2 Spike protein and derivates toxicology :fertility and teratogen eva...Sars-cov2 Spike protein and derivates toxicology :fertility and teratogen eva...
Sars-cov2 Spike protein and derivates toxicology :fertility and teratogen eva...
 
Luisetto M ND agosto 2022 estratto in lingua italiana pubb. 05-08-2022 GRA...
Luisetto M  ND agosto 2022 estratto in lingua italiana pubb. 05-08-2022   GRA...Luisetto M  ND agosto 2022 estratto in lingua italiana pubb. 05-08-2022   GRA...
Luisetto M ND agosto 2022 estratto in lingua italiana pubb. 05-08-2022 GRA...
 
PHYLOSOPHIA ET SCIENTIA.pdf
PHYLOSOPHIA ET SCIENTIA.pdfPHYLOSOPHIA ET SCIENTIA.pdf
PHYLOSOPHIA ET SCIENTIA.pdf
 
Cypress international graduation_programme
Cypress international graduation_programmeCypress international graduation_programme
Cypress international graduation_programme
 
Cbi 7 cypress certificate luisetto m prof.ssorship pharmacology toxicology
Cbi 7 cypress certificate luisetto m prof.ssorship pharmacology   toxicologyCbi 7 cypress certificate luisetto m prof.ssorship pharmacology   toxicology
Cbi 7 cypress certificate luisetto m prof.ssorship pharmacology toxicology
 

Acute care pharmacy program university of arizona pharmaceutical care N 76

  • 1. Acute Care Pharmacy The purpose of the Adult Acute Care Pharmacy Practice rotation is to allow students to gain experience and develop skills in various roles in which a pharmacist contributes to patient care in an inpatient setting. Prior to the rotation, the student should download the Checklist for All Rotations and the Adult Acute Care Rotation Checklist to be used as guides for student activities during the rotation. Preceptors may download an Adult Acute Care Rotation Syllabus template to use as a guide to create a syllabus for their rotation. Adult Acute Care Rotation Goals/Objectives The following are guidelines regarding the activities in which students should gain experience or at least exposure during the Adult Acute Care Rotation. These may be modified to accommodate the student’s previous experience and goals as well as the preceptor's expertise and unique characteristics of a practice site. Overall ratings of the accomplishment of checklist tasks are reflected in items 1 and 2 (Knowledge/Application section) of the form used for the final rotation evaluation and grade assignment. 1. Clinical Pharmacist General Skills • Defines responsibilities of a clinical pharmacy consultant. • Describes strategies for getting clinical pharmacy recommendations implemented. • Describes strategies for dealing with patients or health care providers unhappy with clinical pharmacy recommendations. • Explains strategies for prioritizing clinical pharmacy duties and deciding which patients should receive clinical pharmacy services first when time/staffing is limited such that all patients can’t be seen by a pharmacist. • Describes working structure of the practice site and pharmacy department, including functions of various personnel and their relationship to the pharmacist • Explains and demonstrates aspects of professionalism pertinent to clinical pharmacists. • Demonstrates knowledge of billing procedures applicable to pharmacy services 2. Health Care Planning and Medication Therapy Management
  • 2. • Collects, organizes, and evaluates patient information from various sources including the patient chart, laboratory reports, medication administration records, communications with patient/other health care providers. • Evaluates existing medication therapy including indications of current medications; medication reconciliation on patient admission or transfer; appropriate dosing with respect to age, renal/liver function, alcohol use, and concurrent disease states; appropriate route of administration with respect to GI functional status and other patient specific characteristics; drug-drug interactions; applicable compliance issues; and monitoring parameters. • Applies disease state knowledge to evaluate therapeutic options for given diagnoses. When recommending therapy, considers individual patient contraindications to medications such as allergies, concurrent disease states, and potential drug interactions; recommends appropriate dosing with respect to age renal/liver function, alcohol use, and concurrent disease states; and makes appropriate recommendations for monitoring therapy for adverse effects as well as desired outcomes • Considers social/economic issues that may affect therapy such as patient’s cultural influences, attitude towards care, and personal resources; medication cost; formulary status of medications desired by patient/physician. • Identifies appropriate interventions based on above factors. 3. Patient Care Activities • Reviews/processes medication orders appropriately, if applicable to rotation site. • Performs medication reconciliation activities for newly admitted/transferred patients • Participates in patient care rounds/conferences, analyzing each case presented, answering drug information inquiries in timely manner using appropriate references and research, identifying pertinent questions/issues that are not asked by the other members of the team, and effectively communicating with other members of the health care team. • When appropriate, provides patient education regarding disease state including usual course of disease progression with and without treatment; usual drug and non-drug therapies; and general precautions and recommended lifestyle modifications. • When appropriate, provides patient education regarding medication therapy including indication; dosing/instructions for use; potential side effects and precautions; and potential solutions to compliance problems. • Performs monitoring activities to assess efficacy and potential toxicity of drug therapies while patient is admitted, reporting status to health care team and patient when appropriate. Appropriately explains monitoring goals to patient as well as other health care professionals • Demonstrates communication skills needed for interacting with patients health care team including clear articulation; appropriate terminology; use of open ended questions; prioritization of discussion points; active listening; caring attitude; provision of complete and accurate information.
  • 3. Students should also become familiar with resources available at practice site for communication with non-English speaking patients. • Documents patient care activities according to rotation site procedures 4. Disease State/Therapeutic Knowledge • Demonstrates knowledge of conditions commonly encountered in adult acute care settings, such as diabetes, hypertension, acute coronary syndromes, stroke, asthma/COPD, clotting disorders, acute organ failure, acute/serious infections, trauma. The list should reflect conditions most pertinent to the preceptor’s practice. For these conditions, students should be able to describe basic epidemiology (prevalence/incidence); basic pathophysiology and natural course; usual therapies; situations in which usual therapy is not appropriate for an individual patient; goals of therapy; monitoring parameters; and strategies to prevent complications or acute relapse of the disease. • Demonstrates basic skills in therapeutic drug monitoring including knowledge of drugs commonly monitored using serum concentrations and their usual therapeutic ranges; accurate interpretation of drug concentrations considering timing of sampling with respect to drug administration and other patient specific factors; and recommends appropriate adjustments to therapy based on drug concentrations, using applicable calculations. • Demonstrates basic skills in anticoagulation monitoring including knowledge of indications for prophylactic and therapeutic anticoagulation in hospitalized patients; monitoring parameters for heparin, warfarin, and other anticoagulants; and knowledge of anticoagulant intensity and duration desired for different anticoagulant indications. • Explains monitoring of insulin and oral hypoglycemic agents for efficacy and toxicity, identifying particular concerns for hospitalized patients. • Explains indications for IV hydration and considerations in selecting a particular fluid and rate of administration. • Explains essential considerations in assessing a patient’s acid-base balance • Explains methods for estimation of renal function and drug dosing implications for commonly used agents. • Explains considerations for appropriate use of antibiotics in hospitalized patients including the process for selecting empiric antibiotic use in a non-neutropenic febrile patient; pathogens commonly associated with different types of infections; typical spectrum of activity of commonly used antibiotics; interpretation of gram stain and culture data; adjustments to antibiotic therapy that may be based on culture data; relative costs and potential formulary restrictions of antibiotics used in an institution; duration of antibiotic therapy for different indications; monitoring parameters; aminoglycoside monitoring and dose adjustments. • Demonstrates understanding of basic concepts of nutrition support in hospitalized patients including identification of appropriate candidates for enteral and parenteral nutrition, factors that determine initial TPN/enteral formula for a patient; how/why the initial formula may change during
  • 4. therapy; monitoring required for TPN patients; potential adverse effects of TPN; and factors that determine when/how a TPN should be discontinued. • Demonstrates knowledge of basic concepts of acute pain management including when and how to initiate, monitor, adjust, and discontinue analgesic therapy; assessment of pain; indications for use of opioids, NSAIDs, and other agents used for pain; adverse events associated with opioid and non-opioid analgesics; methods for converting IV analgesics to PO and changing from one opioid compound to another •